$EXAS
EXACT SCIENCES CORP Stock $exas

$exas Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000112414022000030 Filed on April 26, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$486.6M	$473.8M	$402.1M
YoY Change	21.01%	1.6%	15.6%
Cost Of Revenue	$134.7M	$119.1M	$110.0M
YoY Change	22.47%	19.34%	34.79%
Gross Profit	$351.9M	$333.5M	$271.5M
YoY Change	29.59%	-3.61%	10.49%
Gross Profit Margin	72.32%	70.39%	67.53%
Selling, General & Admin	$402.0M	$463.7M	$453.9M
YoY Change	-11.44%	48.47%	61.09%
% of Gross Profit	114.23%	139.02%	167.15%
Research & Development	$102.2M	$40.90M	$115.6M
YoY Change	-11.52%	21.01%	165.62%
% of Gross Profit	29.06%	12.26%	42.56%
Depreciation & Amortization	$22.99M	$45.13M	$20.51M
YoY Change	12.12%	13.1%	28.13%
% of Gross Profit	6.53%	13.53%	7.55%
Operating Expenses	$504.2M	$555.0M	$572.1M
YoY Change	-11.86%	-27.07%	74.35%
Operating Profit	-$177.0M	-$221.5M	-$300.5M
YoY Change	-41.11%	-46.64%	264.85%
Interest Expense	-$5.965M	-$3.404M	$26.57M
YoY Change	-122.45%	-51.37%	5.64%
% of Operating Profit
Other Income/Expense, Net	-$5.965M	-$3.404M	$26.57M
YoY Change	-122.45%	-3.21%	-148.75%
Pretax Income	-$183.0M	-$224.9M	-$274.0M
YoY Change	-33.22%	-48.7%	100.15%
Income Tax	-$2.000M	-$4.243M	-$242.8M
% Of Pretax Income
Net Earnings	-$180.9M	-$220.6M	-$31.16M
YoY Change	480.6%	-47.26%	-76.85%
Net Earnings / Revenue	-37.19%	-46.56%	-7.75%
Basic Earnings Per Share	-$1.04	-$1.28	-$0.18
Diluted Earnings Per Share	-$1.04	-$1.28	-$0.18
COMMON SHARES
Basic Shares Outstanding	174.4M shares	172.4M shares	169.4M shares
Diluted Shares Outstanding	174.4M shares	172.4M shares	169.4M shares

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$817.0M	$1.030B	$1.378B
YoY Change	-40.71%	-44.0%	11.93%
Cash & Equivalents	$189.8M	$315.5M	$1.104B
Short-Term Investments	$627.2M	$715.0M	$274.2M
Other Short-Term Assets	$79.58M	$74.12M	$52.17M
YoY Change	52.54%	123.26%	19.38%
Inventory	$113.0M	$105.0M	$89.03M
Prepaid Expenses
Receivables	$205.6M	$216.6M	$256.1M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.215B	$1.426B	$1.775B
YoY Change	-31.55%	-35.13%	19.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$622.6M	$580.2M	$482.7M
YoY Change	28.98%	28.38%	3.71%
Goodwill	$2.335B	$2.335B	$2.184B
YoY Change	6.93%	88.67%	76.53%
Intangibles	$2.070B	$2.094B	$2.074B
YoY Change	-0.2%	147.24%	83.82%
Long-Term Investments
YoY Change
Other Assets	$77.48M	$74.59M	$56.95M
YoY Change	36.07%	16.97%	164.37%
Total Long-Term Assets	$5.275B	$5.259B	$4.959B
YoY Change	6.38%	92.87%	66.6%
TOTAL ASSETS
Total Short-Term Assets	$1.215B	$1.426B	$1.775B
Total Long-Term Assets	$5.275B	$5.259B	$4.959B
Total Assets	$6.491B	$6.685B	$6.735B
YoY Change	-3.62%	35.73%	50.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$66.47M	$67.83M	$34.70M
YoY Change	91.54%	89.95%	-8.79%
Accrued Expenses	$365.9M	$398.6M	$214.1M
YoY Change	70.87%	70.61%	28.54%
Deferred Revenue	$1.300M	$1.000M	$39.80M
YoY Change	-96.73%	-96.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.400M	$6.200M	$314.2M
YoY Change	-97.96%	-97.59%	1177.04%
Total Short-Term Liabilities	$481.0M	$517.1M	$628.9M
YoY Change	-23.53%	-18.33%	158.2%
LONG-TERM LIABILITIES
Long-Term Debt	$2.193B	$2.193B	$1.885B
YoY Change	16.35%	63.26%	24.48%
Other Long-Term Liabilities	$389.1M	$417.8M	$414.2M
YoY Change	-6.07%	713.72%	776.57%
Total Long-Term Liabilities	$389.1M	$417.8M	$414.2M
YoY Change	-6.07%	713.72%	776.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$481.0M	$517.1M	$628.9M
Total Long-Term Liabilities	$389.1M	$417.8M	$414.2M
Total Liabilities	$3.232B	$3.297B	$3.086B
YoY Change	4.76%	22.6%	60.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.822B	-$2.642B	-$2.077B
YoY Change	35.89%	29.11%	69.49%
Common Stock	$6.087B	$6.031B	$5.726B
YoY Change	6.32%	40.87%	52.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.258B	$3.388B	$3.649B
YoY Change
Total Liabilities & Shareholders Equity	$6.491B	$6.685B	$6.735B
YoY Change	-3.62%	35.73%	50.96%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	-$180.9M	-$220.6M	-$31.16M
YoY Change	480.6%	-47.26%	-76.85%
Depreciation, Depletion And Amortization	$22.99M	$45.13M	$20.51M
YoY Change	12.12%	13.1%	28.13%
Cash From Operating Activities	-$173.8M	-$24.57M	-$77.23M
YoY Change	124.99%	-122.06%	54.99%
INVESTING ACTIVITIES
Capital Expenditures	$33.62M	-$59.39M	$12.92M
YoY Change	160.24%	-86.13%	-0.98%
Acquisitions	$0.00		$343.2M
YoY Change	-100.0%		4942.57%
Other Investing Activities	$7.000K	$137.8M	$141.0K
YoY Change	-95.04%	13.44%	-527.27%
Cash From Investing Activities	$45.56M	$78.44M	-$317.5M
YoY Change	-114.35%	-125.58%	-21.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.735M	-12.20M	$7.245M
YoY Change	-62.25%	-101.39%	-99.26%
NET CHANGE
Cash From Operating Activities	-$173.8M	-24.57M	-$77.23M
Cash From Investing Activities	$45.56M	78.44M	-$317.5M
Cash From Financing Activities	$2.735M	-12.20M	$7.245M
Net Change In Cash	-$125.7M	41.67M	-$387.5M
YoY Change	-67.56%	-93.91%	-173.98%
FREE CASH FLOW
Cash From Operating Activities	-$173.8M	-$24.57M	-$77.23M
Capital Expenditures	$33.62M	-$59.39M	$12.92M
Free Cash Flow	-$207.4M	$34.82M	-$90.15M
YoY Change	130.04%	-93.55%	43.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001124140
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2022Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-35092
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	EXACT SCIENCES CORPORATION
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	02-0478229
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5505 Endeavor Lane
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-4967000	USD
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Madison
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	WI
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	53719
CY2022Q1	dei	City Area Code CityAreaCode	608
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	535-8815
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2022Q1	dei	Trading Symbol TradingSymbol	EXAS
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	175945110	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	189776000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	315471000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24654000	USD
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	627204000	USD
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	715005000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	205625000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	216645000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	112958000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	104994000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	79575000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	74122000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	1215138000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1426237000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	622613000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	580248000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	170373000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	174225000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	2335172000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	2335172000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	365916000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	398556000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2069757000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2094411000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	77484000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	74591000	USD
CY2022Q1	us-gaap	Assets Assets	6490537000	USD
CY2021Q4	us-gaap	Assets Assets	6684884000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	66471000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	67829000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19711000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19710000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	28854000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	30973000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	480952000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	517068000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	3297248000	USD
CY2022Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2181680000	USD
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2180232000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	389062000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	417782000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	180632000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	182166000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	3232326000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	175551408	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	175551408	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	173674067	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	173674067	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	1757000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1738000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6085558000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6028861000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6647000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1443000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2822457000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2641520000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3258211000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3387636000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6490537000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6684884000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	486571000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	402077000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	134705000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	109993000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	102248000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	115567000	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	232181000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	186141000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	169770000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	267727000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24654000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23190000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	663558000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	702618000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-176987000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-300541000	USD
CY2022Q1	exas	Investment Income Expense Nonoperating InvestmentIncomeExpenseNonoperating	-1487000	USD
CY2021Q1	exas	Investment Income Expense Nonoperating InvestmentIncomeExpenseNonoperating	31188000	USD
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4478000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4616000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5965000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	26572000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-182952000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-273969000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2015000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-242805000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-180937000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-31164000	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.04
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.04
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	174417000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	174417000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	169434000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	169434000	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-180937000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-31164000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-31326000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-170000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-186141000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-332000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-237000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	0	USD
CY2022Q1	exas	Comprehensive Income Loss Before Tax ComprehensiveIncomeLossBeforeTax	-186141000	USD
CY2021Q1	exas	Comprehensive Income Loss Before Tax ComprehensiveIncomeLossBeforeTax	-31496000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3387636000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4282000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	52441000	USD
CY2022Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	7000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-180937000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5204000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3258211000	USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	2235552000	USD
CY2021Q1	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	344	shares
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	26000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8759000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	22934000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	158252000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1254798000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-31164000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-162000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	3648995000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-180937000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-31164000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22993000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20508000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-321000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-337000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-1350000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	7000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1912000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-243130000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	52441000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	77292000	USD
CY2022Q1	exas	Post Combination Expense For Acceleration Of Unvested Equity PostCombinationExpenseForAccelerationOfUnvestedEquity	0	USD
CY2021Q1	exas	Post Combination Expense For Acceleration Of Unvested Equity PostCombinationExpenseForAccelerationOfUnvestedEquity	80960000	USD
CY2022Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	USD
CY2021Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	30500000	USD
CY2022Q1	exas	Amortization Deferred Amortization Of Deferred Financing Costs Debt Discounts Premiums And Issuance Costs Other Liabilities AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities	1700000	USD
CY2021Q1	exas	Amortization Deferred Amortization Of Deferred Financing Costs Debt Discounts Premiums And Issuance Costs Other Liabilities AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities	1633000	USD
CY2022Q1	exas	Increase Decrease In Amortization Of Premium On Short Term Investments IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments	956000	USD
CY2021Q1	exas	Increase Decrease In Amortization Of Premium On Short Term Investments IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments	439000	USD
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	7363000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	5740000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11020000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23190000	USD
CY2022Q1	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2021Q1	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	52263000	USD
CY2022Q1	exas	Business Combination Contingent Consideration Gain Loss Change In Fair Value BusinessCombinationContingentConsiderationGainLossChangeInFairValue	26680000	USD
CY2021Q1	exas	Business Combination Contingent Consideration Gain Loss Change In Fair Value BusinessCombinationContingentConsiderationGainLossChangeInFairValue	-2879000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	22950000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7964000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3232000	USD
CY2022Q1	exas	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-5177000	USD
CY2021Q1	exas	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-3120000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-66048000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-15862000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	7834000	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	236295000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-1033000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-173754000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-77227000	USD
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	70267000	USD
CY2021Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	162498000	USD
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	150630000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33623000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12920000	USD
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	343248000	USD
CY2022Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	0	USD
CY2021Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	25000000	USD
CY2022Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1172000	USD
CY2021Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	10000000	USD
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7000	USD
CY2021Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	8697000	USD
CY2022Q1	exas	Business Combination Contingent Consideration Arrangements Increase Due To Acquisition BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2735000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7245000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-237000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1104100000	USD
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	31491000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	141000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	45561000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-317512000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	4282000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	8759000	USD
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1547000	USD
CY2021Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1514000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-125695000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-387494000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315768000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1491594000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190073000	USD
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	297000	USD
CY2021Q1	us-gaap	Restricted Cash RestrictedCash	284000	USD
CY2021Q1	exas	Business Combination Contingent Consideration Arrangements Increase Due To Acquisition BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition	331348000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	5133000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	5274000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	189776000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1103816000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190073000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1104100000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that affect the Company’s financial statements materially and involve difficult, subjective or complex judgments by management, and actual results could differ from those estimates. These estimates include revenue recognition, valuation of intangible assets and goodwill, and accounting for income taxes among others. The Company’s critical accounting policies and estimates are explained further in the notes to the condensed consolidated financial statements in this Quarterly Report and the 2021 Form 10-K.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of the coronavirus (“COVID-19”) has affected many segments of the global economy, including the cancer screening and diagnostics industry. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of March 31, 2022 and through the date of the filing of this Quarterly Report on Form 10-Q. The accounting matters assessed included, but were not limited to, the Company’s allowance for doubtful accounts and credit losses, marketable and non-marketable investments, software, and the carrying value of the goodwill and other long-lived assets. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company’s consolidated financial statements in future reporting periods.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic and related precautionary measures began to materially disrupt the Company's operations in March 2020 and may continue to disrupt the business for an unknown period of time. As a result, the pandemic had an impact on the Company’s revenues and operating results. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate impact of COVID-19 depends on factors beyond the Company’s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the extent to which COVID-19 will negatively impact its financial results or liquidity.</span></div>
CY2022Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation in the condensed consolidated financial statements and accompanying notes to the condensed consolidated financial statements.</span></div>
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30098000	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28412000	shares
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	486571000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	402077000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1300000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1000000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	300000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	14000000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	14000000	USD
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	297000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	297000	USD
CY2022Q1	us-gaap	Cash Cash	135320000	USD
CY2021Q4	us-gaap	Cash Cash	247335000	USD
CY2022Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	54456000	USD
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	68136000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190073000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315768000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1821000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	3336000	USD
CY2022Q1	us-gaap	Marketable Securities MarketableSecurities	627204000	USD
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	715005000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	817277000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	1030773000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	686272000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6433000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	679839000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	781271000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	17000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1483000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	779805000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	357656000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	355695000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	328616000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	324144000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	605453000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	6433000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	605453000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	6433000	USD
CY2022Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	55402000	USD
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	51321000	USD
CY2022Q1	exas	Inventory Finished And Semi Finished Goods InventoryFinishedAndSemiFinishedGoods	57556000	USD
CY2021Q4	exas	Inventory Finished And Semi Finished Goods InventoryFinishedAndSemiFinishedGoods	53673000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	112958000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	104994000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	859744000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	795064000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	237131000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	214816000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	622613000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	580248000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	23000000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	20500000	USD
CY2022Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	123900000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1042808000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	223051000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	819757000	USD
CY2022Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	USD
CY2022Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	USD
CY2022Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2292808000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	223051000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2069757000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1042808000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	198397000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	844411000	USD
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	USD
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2292808000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	198397000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2094411000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	73962000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	98611000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	98276000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	97228000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	96169000	USD
CY2022Q1	exas	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	355511000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	819757000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1237672000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	2335172000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	2335172000	USD
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	332300000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	359000000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	359021000	USD
CY2022Q1	exas	Business Combination Contingent Consideration Gain Loss Change In Fair Value BusinessCombinationContingentConsiderationGainLossChangeInFairValue	26680000	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	332341000	USD
CY2022Q1	exas	Debt Instrument Repurchase Price Due To Change In Control As Percentage Of Principal Amount DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount	100
CY2022Q1	us-gaap	Share Price SharePrice	69.92
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1412000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1413000	USD
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	36000	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	36000	USD
CY2022Q1	exas	Coupon Interest Expense CouponInterestExpense	2567000	USD
CY2021Q1	exas	Coupon Interest Expense CouponInterestExpense	2567000	USD
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	4015000	USD
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	4016000	USD
CY2022Q1	us-gaap	Interest Expense Other InterestExpenseOther	463000	USD
CY2021Q1	us-gaap	Interest Expense Other InterestExpenseOther	600000	USD
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4478000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4616000	USD
CY2022Q1	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-5231000	USD
CY2022Q1	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	-27000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-5204000	USD
CY2021Q1	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-292000	USD
CY2021Q1	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	40000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-332000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-170000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8800000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52400000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	163500000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4300000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	8097000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	5558000	USD
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	211000	USD
CY2021Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	248000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1548000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1203000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4259000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	40406000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	878000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	639000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y2M1D
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y8M8D
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2021Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y5M12D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0609
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0641
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0532
CY2021Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0566
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	200300000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	170400000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	174200000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19700000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	180600000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	201900000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19700000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	182200000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	17400000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	18200000	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	18000000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	6400000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	11600000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	18700000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	6200000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	12500000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	486571000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	402077000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2000000.0	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-242800000	USD
CY2022Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	26400000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	23100000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	21800000	USD

Files In Submission

Name	View Source	Status
0001124140-22-000030-index-headers.html	Edgar Link	pending
0001124140-22-000030-index.html	Edgar Link	pending
0001124140-22-000030.txt	Edgar Link	pending
0001124140-22-000030-xbrl.zip	Edgar Link	pending
exas-20220331.htm	Edgar Link	pending
exas-20220331.xsd	Edgar Link	pending
exas-20220331xexx101.htm	Edgar Link	pending
exas-20220331xexx102.htm	Edgar Link	pending
exas-20220331xexx311.htm	Edgar Link	pending
exas-20220331xexx312.htm	Edgar Link	pending
exas-20220331xexx321.htm	Edgar Link	pending
exas-20220331_cal.xml	Edgar Link	unprocessable
exas-20220331_def.xml	Edgar Link	unprocessable
exas-20220331_htm.xml	Edgar Link	completed
exas-20220331_lab.xml	Edgar Link	unprocessable
exas-20220331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXAS
EXACT SCIENCES CORP Stock $exas

2022 Q1 Form 10-Q Financial Statement

#000112414022000030 Filed on April 26, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS EXACT SCIENCES CORP Stock $exas

2022 Q1 Form 10-Q Financial Statement

#000112414022000030 Filed on April 26, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS
EXACT SCIENCES CORP Stock $exas